Summit Wealth & Retirement Planning Inc. bought a new stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,637 shares of the financial services provider’s stock, valued at approximately $451,000.
Several other hedge funds have also made changes to their positions in CME. Vanguard Group Inc. lifted its position in CME Group by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider’s stock valued at $9,190,661,000 after purchasing an additional 400,737 shares during the last quarter. Raymond James Financial Inc. increased its stake in shares of CME Group by 9.7% in the first quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider’s stock valued at $1,091,401,000 after purchasing an additional 363,130 shares during the period. Vontobel Holding Ltd. increased its stake in shares of CME Group by 3.0% in the second quarter. Vontobel Holding Ltd. now owns 2,920,046 shares of the financial services provider’s stock valued at $804,823,000 after purchasing an additional 84,005 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in shares of CME Group by 29.9% during the first quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider’s stock valued at $747,744,000 after buying an additional 648,591 shares during the last quarter. Finally, AQR Capital Management LLC boosted its position in shares of CME Group by 10.3% during the first quarter. AQR Capital Management LLC now owns 2,783,759 shares of the financial services provider’s stock worth $735,539,000 after buying an additional 260,065 shares during the period. Institutional investors own 87.75% of the company’s stock.
Insider Activity at CME Group
In other news, Director William R. Shepard bought 262 shares of the firm’s stock in a transaction on Thursday, September 25th. The stock was bought at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the acquisition, the director directly owned 258,459 shares in the company, valued at $68,540,742.21. This represents a 0.10% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total transaction of $263,530.00. Following the sale, the director owned 1,091 shares in the company, valued at $287,511.23. This represents a 47.82% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 14,043 shares of company stock valued at $3,791,486. Corporate insiders own 0.30% of the company’s stock.
CME Group Price Performance
CME Group (NASDAQ:CME – Get Free Report) last announced its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the firm earned $2.68 earnings per share. CME Group’s revenue for the quarter was down 3.0% compared to the same quarter last year. As a group, equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be paid a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. CME Group’s dividend payout ratio is currently 48.45%.
Analyst Ratings Changes
Several analysts recently commented on CME shares. JPMorgan Chase & Co. raised their target price on CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research report on Tuesday, October 14th. The Goldman Sachs Group raised their price target on CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a report on Thursday, October 23rd. Barclays cut their price objective on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 8th. Wall Street Zen lowered shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Finally, Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and upped their price target for the stock from $275.00 to $300.00 in a research note on Thursday, September 25th. Eight analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $286.06.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- MarketBeat Week in Review – 11/03 – 11/07
- Ride Out The Recession With These Dividend Kings
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- Canada Bond Market Holiday: How to Invest and Trade
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
